{{t.slogan.system}}
{{t.slogan.network}}
{{t.slogan.access}}
{{t.languages.spa}}
{{t.languages.en}}
Iatreia
{{t.tooltip}}
2007,
20
(1)
2024
37
(1)
2023
36
(1)
36
(2)
36
(4)
2022
35
(1)
35
(2)
35
(3)
35
(4)
2021
34
(1)
34
(2)
34
(3)
34
(4)
2020
33
(1)
33
(2)
33
(3)
33
(4)
2019
32
(1)
32
(2)
32
(3)
32
(4)
2018
31
(1)
31
(2)
31
(4)
31
(3)
2017
30
(1)
30
(2)
30
(3)
30
(4)
2016
29
(1)
29
(2)
29
(3)
29
(4)
Sup.
29
(4)
2015
28
(1)
28
(2)
28
(3)
28
(4)
2014
27
(1)
27
(2)
27
(3)
27
(4)
2013
26
(1)
26
(2)
26
(3)
26
(4)
Sup.
26
(3)
Sup.
26
(4)
2012
25
(2)
25
(1)
25
(3)
25
(4)
2011
24
(4)
24
(1)
24
(3)
24
(2)
2010
23
(4)
23
(3)
23
(1)
23
(2)
Sup.
23
(4)
2009
22
(1)
22
(2)
22
(4)
22
(3)
2008
21
(1)
21
(2)
21
(3)
Sup.
21
(1)
21
(4)
Sup.
21
(4)
2007
20
(1)
20
(3)
20
(2)
20
(4)
- Sup.
20
(1)
Sup.
20
(1)
2006
19
(1)
19
(3)
19
(4)
19
(2)
2005
18
(4)
18
(3)
18
(2)
18
(1)
{{t.download}}
Hepatocellular carcinoma - Global burden and risk factors
HUBERT E. BLUM.
Iatreia
PDF
Hepatocellular carcinoma in cirrhotic liver CT an MRI findings
GERMÁN CASTRILLÓN.
Iatreia
PDF
Pathology of liver tumors
GERMAN OSORIO SANDOVAL.
Iatreia
PDF
Liver transplant in HCC
SERGIO I. HOYOS DUQUE.
Iatreia
PDF
Immunosupression in liver transplant for hepatocellular carcinoma
JUAN-CARLOS RESTREPO.
Iatreia
PDF
Oxidative stress and inflammation in liver carcinogenesis
NATALIA OLAYA.
Iatreia
PDF
Proteomics for the early diagnosis and treatment of hepatocellular carcinoma
VIJAY KUMAR.
Iatreia
PDF
The Gambia hepatitis intervention study (GHIS)
PIERRE HAINAUT.
Iatreia
PDF
HCC Biomarkers in China and Taiwan
REGINA M. SANTELLA.
Iatreia
PDF
Interplay between viral infections and genetic alterations in liver cancer
PIERRE HAINAUT.
Iatreia
PDF
Hepatocellular carcinoma (HCC) biomarkers in Colombia
MARÍA-CRISTINA NAVAS.
Iatreia
PDF
Epidemiology of hepatocellular carcinoma
RAYMUNDO PARANÁ,
DELVONE ALMEIDA.
Iatreia
PDF
Hepatitis B virus DNA integration and transactivation of cellular genes
VIJAY KUMAR.
Iatreia
PDF
Cell cycle deregulation by the HBx protein of hepatitis B virus
VIJAY KUMAR.
Iatreia
PDF
Hepatitis infections, aflatoxin and hepatocellular carcinoma
PIERRE HAINAUT.
Iatreia
PDF
Occult HBV infection and HCC
ISABELLE CHEMIN.
Iatreia
PDF
HCV and HCC molecular epidemiology
FLOR H. PUJOL.
Iatreia
PDF
Molecular basis of hepatitis C virus -associated hepatocarcinogenesis
ISABELLE CHEMIN.
Iatreia
PDF
HBV And HCV Molecular Evolution
FLOR H. PUJOL.
Iatreia
PDF
Animal models for HCV and HBV studies
ISABELLE CHEMIN.
Iatreia
PDF
Genetic alterations and epigenetic changes in hepatocarcinogenesis
LUZ STELLA HOYOS GIRALDO.
Iatreia
PDF
Aflatoxin B1: Mechanism of mutagenesis
REGINA M. SANTELLA.
Iatreia
PDF
Methylation in hepatocellular carcinoma
REGINA M. SANTELLA.
Iatreia
PDF
TP53 and Beta-catenin mutations in liver tumours
PIERRE HAINAUT.
Iatreia
PDF
Exploration of new HCC biomarkers
REGINA M. SANTELLA.
Iatreia
PDF
The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers
AUDREY PETITJEAN,
PIERRE HAINAUT,
MAGALI OLIVIER.
Iatreia
PDF
Clinical and laboratory features of hepatocellular carcinoma
MARIA C. LONDOÑO,
ANDRÉS CÁRDENAS.
Iatreia
PDF
title
content